Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ECYT:US

6.1700 USD 0.1300 2.06%

As of 20:10:00 ET on 04/24/2015.

Company Profile for Endocyte Inc (ECYT)

Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, or SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.

Contact Information

Endocyte Inc

3000 Kent Avenue
Suite A 1-100
West Lafayette, IN 47906
United States
Phone: 1-765-463-7175
Fax: 1-765-463-9271

Key Executives for Endocyte Inc (ECYT)

P Ron EllisPresident/CEO/Co-FounderMichael A ShermanCFO/COO
Philip S LowChief Science Ofcr/Co-FounderChristopher P LeamonVP:Research
Katherine K ParkerVP:Human ResourcesMichael A BrinkleyVP:Quality
Scot L Harper "Scot"VP:Clinical OperationsBeth A TaylorController

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil